Search

The Metastasis Research Center has brought together 27 Memorial Sloan Kettering laboratories to facilitate research on metastasis and its treatment.

… Tuesday, June 1, 2010 Summary The Metastasis Research Center has brought together 27 Memorial Sloan Kettering laboratories to facilitate research on metastasis and its treatment. Until recently, little was known about the underlying causes of metastasis. Yet the special abilities some tumor cells have

Genetic sequencing of prostate tumors can identify men who should receive immunotherapy drugs.

… Friday, January 11, 2019 Summary Immunotherapy drugs called checkpoint inhibitors can be very effective but don’t work for most people with prostate cancer . A small subset of men whose prostate tumors have a genetic abnormality called high microsatellite instability do respond to the drugs. Genetic

… Tuesday, August 21, 2012 Summary A team of researchers has made a breakthrough in solving a problem that has defied biologists for decades: How to compute a protein’s three-dimensional structure, or shape, based on genetic information. The discovery could accelerate diverse areas of biomedical discovery

This form of cell death is called ferroptosis, and certain cancer cells are especially vulnerable to it.

… Tuesday, August 27, 2019 Summary The same properties that make certain cancers hard to treat may also promote their death by ferroptosis, scientists at the Sloan Kettering Institute have found. Cells can die in several ways. One such method, discovered only within the past decade, is ferroptosis — literally

In a recently published paper MSK's Jun Mao explores the global challenges of cancer control and the current status of integrative oncology, offering recommendations to improve access to safe, effective, evidence-based, and culturally sensitive cancer care.

… Thursday, November 18, 2021 Cancer is a global health challenge that impacts countries large and small, affluent and impoverished. With population growth and aging, and success in the management of other acute and chronic diseases, the number of new cancer cases is expected to rise over the next two

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Thursday, April 15, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Katharine Hsu Named Director of Tri-Institutional MD-PhD Program Katharine Hsu MSK’s Katharine Hsu, MD, PhD , has been named director of the Tri-Institutional MD-PhD Program , a joint

A novel treatment for prostate cancer involves a light-sensitive drug that destroys small tumors and the blood vessels that feed them.

… Monday, September 18, 2017 Summary Treatment of prostate cancer involves the risk of complications that can reduce quality of life. MSK researchers are exploring a new technology called vascular-targeted photodynamic therapy to help alleviate this risk. It can destroy small prostate tumors with a drug

The new Evelyn H. Lauder Breast Center of Memorial Sloan Kettering Cancer Center and the Memorial Sloan Kettering Cancer Center Imaging Center have opened, offering patients the most advanced outpatient services for cancer diagnosis and breast cancer treatment and detection.

… Monday, October 5, 2009 The new Evelyn H. Lauder Breast Center of Memorial Sloan Kettering Cancer Center (MSKCC) and the MSKCC Imaging Center have opened, offering patients the most advanced outpatient services for cancer diagnosis and breast cancer treatment and detection. VIDEO | 5:00 Virtual Tour

Craig B. Thompson, MD, President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to City & State’s 2022 Health Care Power 100 list.

… Wednesday, January 26, 2022 Craig B. Thompson, MD , President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to City & State ’s 2022 Health Care Power 100 list . The prestigious Health Care Power list recognizes the most influential public health officials, hospital executives

A new study from Kenneth Offit, MD, Chief of the Clinical Genetics Service and Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center (MSK), finds that more than half of inherited cancer gene mutations in people with advanced cancer are not detected using traditional methods based on family history.

… Tuesday, September 5, 2017 Bottom Line A new study from Kenneth Offit, MD , Chief of the Clinical Genetics Service and Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center (MSK), finds that more than half of inherited cancer gene mutations in people with